CIK 0000842023
- Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- Operating
- EIN
- 411427402
- Phone
- +1 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-08-17 | LUCAS ROGER C Director | Exercise or conversion · Stock Option (right to buy) | −5,000 | 0 | ||
| 2015-08-13 | LUCAS ROGER C Director | Exercise or conversion | +5,000 | $61.46 | $307K | 8,456 |
| 2015-08-13 | LUCAS ROGER C Director | Sale | −5,000 | $106.01 | $530K | 3,456 |
| 2015-08-13 | LUCAS ROGER C Director | Exercise or conversion · Stock Option (right to buy) | −5,000 | 0 | ||
| 2015-08-07 | Eansor Norman David SVP - Novus Biologicals | Grant or award · Stock Option (Right to Buy) | +9,375 | 9,375 | ||
| 2015-08-07 | Eansor Norman David SVP - Novus Biologicals | Grant or award · Restricted Stock Units | +1,500 | 1,500 | ||
| 2015-08-07 | Eansor Norman David SVP - Novus Biologicals | Grant or award · Stock Option (Right to Buy) | +9,375 | 9,375 | ||
| 2015-08-07 | Eansor Norman David SVP - Novus Biologicals | Grant or award · Restricted Stock Units | +1,500 | 1,500 | ||
| 2015-08-07 | Gavin Robert M. Senior V.P. Protein Platforms | Grant or award · Stock Option (Right to Buy) | +9,375 | 9,375 | ||
| 2015-08-07 | Gavin Robert M. Senior V.P. Protein Platforms | Grant or award · Restricted Stock Units | +1,500 | 1,500 | ||
| 2015-08-07 | VERONNEAU MARCEL SVP - Clinical Controls | Grant or award · Stock Option (Right to Buy) | +5,625 | 5,625 | ||
| 2015-08-07 | VERONNEAU MARCEL SVP - Clinical Controls | Grant or award · Restricted Stock Units | +900 | 900 | ||
| 2015-08-07 | Furlow Brenda S. SVP - General Counsel | Grant or award · Restricted Stock Units | +1,200 | 1,200 | ||
| 2015-08-07 | Furlow Brenda S. SVP - General Counsel | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2015-08-07 | Kummeth Charles R. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +119,275 | 119,275 | ||
| 2015-08-07 | Kummeth Charles R. Chief Executive Officer | Grant or award · Restricted Stock Unit | +17,283 | 17,283 | ||
| 2015-08-07 | Bazan J. Fernando Chief Technical Officer | Grant or award · Stock Options (Right to Buy) | +7,500 | 7,500 | ||
| 2015-08-07 | Bazan J. Fernando Chief Technical Officer | Grant or award · Restricted Stock Units | +1,200 | 1,200 | ||
| 2015-08-07 | Hippel James Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +18,750 | 18,750 | ||
| 2015-08-07 | Hippel James Chief Financial Officer | Grant or award · Restricted Stock Unit | +3,000 | 3,000 |
Page 65 of 75 · 1,487 trades